Saitama, Japan

Kenji Sugihayashi

This inventor holds 1 USPTO granted patent. Top assignees: Josai University Corporation, Nelson-Sumisho Co., Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Sugihayashi. Retrieved from https://idiyas.com/inventor/kenji-sugihayashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Sugihayashi: Innovator in AIDS Treatment

Introduction

Kenji Sugihayashi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of AIDS. His innovative approach to drug administration has garnered attention in the medical community.

Latest Patents

Sugihayashi holds a patent for a method of administering 3'-azide-3'-deoxythymidine (AZT) to AIDS patients. This method involves applying AZT to the skin of patients along with an absorption-promoting agent. The composition is designed to enhance the absorption of AZT through the skin into the bloodstream, providing an effective treatment option for those in need.

Career Highlights

Throughout his career, Sugihayashi has worked with various organizations, including Nelson-Sumisho Co., Ltd. and Josai University Corporation. His work has focused on developing innovative solutions to improve patient care and treatment efficacy.

Collaborations

Sugihayashi has collaborated with notable colleagues such as Toshinobu Seki and Yasunori Morimoto. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Kenji Sugihayashi's contributions to AIDS treatment through innovative drug administration methods highlight his role as a significant inventor in the medical field. His work continues to impact patient care positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…